Log In
Print this Print this

parsatuzumab (RG7414, RO5490248)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionHumanized mAb against EGF-like-domain multiple 7 (EGFL7)
Molecular Target EGF-like-domain multiple 7 (EGFL7)
Mechanism of ActionAngiogenesis inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerChugai Pharmaceutical Co. Ltd.;
Genentech Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today